News

◄ Back

June 2, 2003 Germantown, WI USA: Cambridge Major Laboratories today announced it is breaking ground on a new facility to be located in a new industrial park near its existing site in Germantown Wisconsin. The 50,000 square foot cGMP facility represents the future of Cambridge Major and underscores the company’s continuing strength in a generally weak custom chemicals marketplace.

Once completed, Cambridge Major will consolidate the operation of its two existing facilities into the new site. The new facility will house 9 kilo laboratories, 2 high-potency suites, 2 mini pilot plants, 2 main plants, 2 analytical and 1 spectroscopy laboratory. The facility effectively positions Cambridge Major to compete further into the clinical development cycle, as well as expand its ability to handle more post-NDA commercial API manufacturing relationships.

The facility has been financed largely by industrial revenue bonds through the State of Wisconsin, as well as cash. No venture capital, external partners, or other financial instruments have been used in the financing of the new facility which is expected to be completed by the Summer of 2004. The project will create additional 20-30 jobs, mostly chemists and operators.

“I am very pleased at the progress of Cambridge Major over the past several years, although we’ve had to work twice as hard”, said Michael W. Major, Ph.D., D.Sc, President and CEO of Cambridge Major Labs. “Our growth has been quite remarkable. Even in these generally tough times in contract chemistry, we have more than managed to survive. We’ve maintained profitability, and we will be uniquely positioned next year to capitalize on more opportunities…particularly as the market rebounds.”

Most of the equipment for the new facility has already been acquired via a number of strategic acquisitions including the assets of the former Oread API Plant announced November 18, 2002. In addition to those assets Cambridge Major is acquiring other equipment including reactors up to 500 gallon, solids handling equipment, glove box technology, and other process and analytical instrumentation. “Actually there is a positive side in this economic downturn for those who have managed to stay afloat….lot’s of equipment is available at very attractive prices”, says Major. “It runs against the grain to think these “bad times” have allowed us to build a facility, that a few years ago may have been out of our reach.”


Cambridge Major Laboratories, Inc. is a service-based chemistry outsourcing partner to the world’s leading pharmaceutical and biotechnology companies, producing pharmaceutical intermediates, API’s, and other fine organic chemicals. Specializing in chemical process development and advanced multi-step organic synthesis, the Company operates two facilities near Milwaukee, Wisconsin including process chemistry laboratories, kilo labs, a pilot plant, and complete analytical laboratories. The Company has been FDA inspected and approved for cGMP manufacturing. Visit us at www.cambridgemajorlabs.com.

◄ Back